Agents that inhibit the effects of cytokines and growth factors such as TNFα, TGFβ, VEGF, and HGF, all involved in the increase of vascular permeability, decrease transepithelial/endothelial resistance and increase paracellular permeability, could be a useful tool against cancer metastasis. Here, TGFB1 is linked to cancer.